دورية أكاديمية

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

التفاصيل البيبلوغرافية
العنوان: Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
المؤلفون: Meulenbeld, H.J., van Werkhoven, E.D., Coenen, J.L.L.M., Creemers, G.J., Loosveld, O.J.L., de Jong, P.C., ten Tije, A.J., Fosså, S.D., Polee, M., Gerritsen, W., Dalesio, O., de Wit, R.
المصدر: In European Journal of Cancer November 2012 48(16):2993-3000
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09598049
DOI:10.1016/j.ejca.2012.05.014